GABA.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

DCF fair valuemodel estimate

Intrinsic value

$0.01

Price

$0.03

Implied downside

-51%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
GABA.STGabather AB (publ)	$0.03	+2.92%	$7M	—
CMH.STChordate Medical Holding AB (publ)	$0.10	-37.50%	$269962	—
FLUI.STFluicell AB (publ)	$30.70	-6.40%	$42M	—
LIDDS.STLIDDS AB (publ)	$0.02	+0.00%	$3M	—
ODI.STODI Pharma AB	$2.04	-0.00%	$37M	—
PLUN.STProstaLund AB (publ)	$0.21	-35.15%	$775547	—
QUIA.STQuia Pharma AB (publ)	$0.00	-16.67%	$1M	—

Source: Financial Modeling Prep · peers by sector/industry

Gabather AB (publ)

Gabather AB (publ) is dedicated to creating innovative pharmaceutical solutions for a range of central nervous system disorders. The company's focus includes developing medications for conditions such as psychotic illnesses, mood and anxiety disorders, pain relief, and cognitive function enhancement, notably those related to Alzheimer's disease. Founded in 2014, its operations are headquartered in Södertälje, Sweden.

www.gabather.com

Employees: 2
IPO / List date: Nov 3, 2014
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds GABA.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in GABA.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded GABA.ST yet.